Anders Karlsson new President of LinkMed

The board of directors has appointed Anders Karlsson as new president. He succeeds the company’s founder Ingemar Lagerlöf who leaves the company after 13 years, five of which as president. The change takes place today.

Anders Karlsson comes from the position as president of LinkMed’s subsidiary AbSorber AB and has more than 20 years experience from the pharmaceutical industry.

”The company now enters a new phase with the focus entirely on the transplantation business. Therefore, it is a natural step to change the management of the company”, says Monica Caneman, chairwoman of the board. “Anders Karlsson with his background in AbSorber and with long experience of marketing and sales is well placed to further strengthen the company’s market position. A priority is also to form the parent company, AbSorber and Olerup SSP into a joint organization in order to achieve increased efficiency and lower costs.”

For further information, please contact:
Monica Caneman, chairwoman of the board, tel +46 70 295 17 37

LinkMed AB discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 08:05 (CET) on May 25, 2011.

LinkMed's activities are mainly focused on the commercial transplant operations with product companies AbSorber and Olerup SSP and sales and distribution companies Olerup Inc. and Olerup GmbH. LinkMed also has a portfolio of associated companies in life science companies, with four companies active in biotechnology and six companies operating in diagnostics and medical device. LinkMed is listed on NASDAQ OMX Stockholm Small Cap (ticker: LMED).